日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cell-targeted PD-1 agonists are potent NK-cell inhibitors

靶向细胞的PD-1激动剂是强效的NK细胞抑制剂。

Harriet C Pope,Ana L Chiodetti,Alice Newey,Guillaume Rieunier,David X Overton,Eduardo Mateos-Diaz,Tara M Mahon,Giovanna Bossi,Hussein Al-Mossawi,Charlotte Viant

Cell-targeted PD-1 agonists are potent NK-cell inhibitors

靶向细胞的PD-1激动剂是强效的NK细胞抑制剂。

Harriet C Pope ,Ana L Chiodetti ,Alice Newey ,Guillaume Rieunier ,David X Overton ,Eduardo Mateos-Diaz ,Tara M Mahon ,Giovanna Bossi ,Hussein Al-Mossawi ,Charlotte Viant

High-affinity T cell receptor ImmTAC® bispecific efficiently redirects T cells to kill tumor cells expressing the cancer-testis antigen PRAME

高亲和力 T 细胞受体 ImmTAC® 双特异性有效重定向 T 细胞以杀死表达癌睾丸抗原 PRAME 的肿瘤细胞

Ana R Ribeiro, Camille Britton-Rivet, Laura Collins, Ricardo J Carreira, Sylvie Moureau, Adel Benlahrech, Sarah Stanhope, Stephen Harper, Nathaniel Liddy, Tara M Mahon, Kristina Petrovic, Mark Fife, David Depoil, Philip Addis, Nicole Bedke, Lucie Bouard, Ronan O'Dwyer, Duncan Gascoyne, Koustubh Rana

Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitors

靶向细胞的PD-1激动剂(模拟PD-L1)是强效的T细胞抑制剂。

Adam P Curnock, Giovanna Bossi, Jyothi Kumaran, Lindsay J Bawden, Rita Figueiredo, Rajeevkumar Tawar, Katherine Wiseman, Emma Henderson, Sec Julie Hoong, Veronica Gonzalez, Hemza Ghadbane, David Eo Knight, Ronan O'Dwyer, David X Overton, Christina M Lucato, Nicola Mg Smith, Carlos R Reis, Keith Page, Lorraine M Whaley, Michelle L McCully, Stephen Hearty, Tara M Mahon, Peter Weber

Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions

TCR CDR中的单个或两个氨基酸替换可以增强抗原特异性T细胞功能。

Paul F Robbins,Yong F Li, Mona El-Gamil, Yangbing Zhao, Jennifer A Wargo, Zhili Zheng, Hui Xu, Richard A Morgan, Steven A Feldman, Laura A Johnson, Alan D Bennett, Steven M Dunn, Tara M Mahon, Bent K Jakobsen, Steven A Rosenberg